Our CEO Immanuel Lerner will be attending & presenting at the NextGen Biomed 2025 in London, March 12-13

Join our CEO, Immanuel Lerner for insights on AI-driven peptide drug discovery:
📅 March 12:
🗝 Keynote – Orally Available Peptides | 9:55 AM
💡 Panel – Novel Peptide Therapeutics | 12:30 PM

📅 March 13:
🎙 Moderator – Optimizing Drug Candidates | 2:15 PM